GLOMERULAR DISEASE
Clinical trials for GLOMERULAR DISEASE explained in plain language.
Never miss a new study
Get alerted when new GLOMERULAR DISEASE trials appear
Sign up with your email to follow new studies for GLOMERULAR DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney disease: Long-Term drug safety trial launches
Disease control Recruiting nowThis study looks at the long-term safety of a drug called zigakibart for adults with IgA nephropathy, a kidney disease. It is for people who have already finished another zigakibart study. The goal is to see if the drug remains safe and helpful over time.
Matched conditions: GLOMERULAR DISEASE
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 10:28 UTC
-
New combo therapy aims to calm overactive immune system in kidney disease
Disease control Recruiting nowThis study is testing whether combining two immune-suppressing drugs, rituximab and cyclosporine, can safely and effectively treat membranous nephropathy, a kidney disease where the immune system attacks the kidneys, causing protein to leak into urine. About 30 adults with persis…
Matched conditions: GLOMERULAR DISEASE
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated May 11, 2026 20:53 UTC
-
Swelling stories: new survey aims to improve kidney drug tests
Knowledge-focused Recruiting nowThis study interviews 150 children, adults, and parents about their experiences with swelling caused by Nephrotic Syndrome. Researchers will use the information to create a survey that helps test new medications. No treatment is given; the goal is to better understand symptoms.
Matched conditions: GLOMERULAR DISEASE
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated May 11, 2026 20:46 UTC